-
Pharmacological treatments for alcohol dependence: Evidence on uptake, inequalities and comparative effectiveness from a UK population‐based cohort Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-04-24 Francesco Manca, Lisong Zhang, Niamh Fitzgerald, Frederick Ho, Hamish Innes, Bhautesh Jani, Srinivasa Vittal Katikireddi, Andrew McAuley, Clare Sharp, Jim Lewsey
IntroductionWe assessed the prevalence of prescribing of certain medications for alcohol dependence and the extent of any inequalities in receiving prescriptions for individuals with such a diagnosis. Further, we compared the effectiveness of two of the most prescribed medications (acamprosate and disulfiram) for alcohol dependence and assessed whether there is inequality in prescribing either of them
-
A qualitative study of using nicotine products for smoking cessation after discharge from residential drug and alcohol treatment in Australia Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-04-24 Joshua Trigg, Jane Rich, Edwina Williams, Amanda Baker, Linda Bauld, Ron Borland, Chris Bullen, Mark Daglish, Adrian Dunlop, Coral Gartner, David Jacka, Dan Lubman, Victoria Manning, Rose McCrohan, Cathy Segan, Natalie Walker, Billie Bonevski
IntroductionTobacco smoking is highly prevalent among alcohol and other drugs (AOD) service clients and, despite interest in quitting, abstinence is rarely sustained. Nicotine products may assist after discharge from residential treatment services, but little is known about client receptivity to them. This study examined AOD withdrawal service clients' experiences of two types of nicotine products
-
Stigma, and factors associated with experiencing stigma, while visiting health‐care services among samples of people who use illegal drugs in Australia Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-04-22 Rachel Sutherland, Cate King, Antonia Karlsson, Carla Treloar, Timothy Broady, Udesha Chandrasena, Caroline Salom, Paul Dietze, Amy Peacock
IntroductionPeople who inject drugs experience stigma across multiple settings, including when accessing health‐care services, however, comparatively little is known about experiences of stigma towards other groups of people who use illegal drugs. This paper examines experience of, and factors associated with, stigma among two samples of people who use illegal drugs when visiting both specialist alcohol
-
Opioid use, prescribing and fatal overdose patterns among racial/ethnic minorities in the United States: A scoping review and conceptual risk environment model Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-04-22 Jerel M. Ezell, Mai T. Pho, Babatunde P. Ajayi, Elinor Simek, Netra Shetty, Dawn A. Goddard‐Eckrich, Ricky N. Bluthenthal
IssuesTo date, there has been no synthesis of research addressing the scale and nuances of the opioid epidemic in racial/ethnic minority populations in the United States that considers the independent and joint impacts of dynamics such as structural disadvantage, provider bias, health literacy, cultural norms and various other risk factors.ApproachUsing the “risk environment” framework, we conducted
-
Digital alcohol marketing and gender: A narrative synthesis Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-04-22 Antonia C. Lyons, Kate Kersey, Carol Emslie, Elena Dimova, Annamae Burrows
IssuesAlcohol marketing on social media platforms is pervasive and effective, reaching wide audiences and allowing interaction with users. We know little about the gendered nature of digital alcohol marketing, including how women and men are portrayed, how different genders respond and implications for gender relations. This review aimed to identify how males, females and other genders are targeted
-
Alcohol screening in 22 Australian Aboriginal Community Controlled Health Organisations: Clinical context and who is screened Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-04-19 Teagan J. Weatherall, James H. Conigrave, K. S. Kylie Lee, Julia Vnuk, Rowena Ivers, Noel Hayman, Scott Wilson, Dennis Gray, Katherine M. Conigrave
IntroductionAlcohol screening among Indigenous Australians is important to identify individuals needing support to reduce their drinking. Understanding clinical contexts in which clients are screened, and which clients are more or less likely to be screened, could help identify areas of services and communities that might benefit from increased screening.MethodsWe analysed routinely collected data
-
Enhancing the SUSTAINable uptake of evidence to minimise harms from alcohol and other drugs in New South Wales, Australia Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-04-18 Sara Farnbach, Catherine Foley, Peter Gates, Alison Seccull, Alexandra Henderson, Andrea Zocco, Michael Farrell, Anthony Shakeshaft
Although alcohol and other drug use is increasingly the focus of policy and research efforts, there are challenges identifying and applying evidence‐based strategies to minimise harms for alcohol and other drugs in health care and community settings. These challenges include limited available research, variability across settings, and lack of ‘fit’ between research evidence and their intended settings
-
‘The wild west of medicine’: A qualitative investigation of the factors influencing Australian health‐care practitioners' delivery of medicinal cannabis Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-04-17 Olivia Dobson, Michaela Barber, Myfanwy Graham, Adrian Carter, Michael Savic
IntroductionStrong patient interest in the use of medicinal cannabis to treat various clinical indications has sparked global legislative changes. Practitioners are vital in implementing regulatory changes and facilitating patient access to medicinal cannabis, however, little is currently known about the factors influencing practitioners' uptake. Recent rapid increases in practitioner applications
-
‘Everywhere I call, there's nothing available’: Understanding the alcohol treatment landscape and needs among unstably housed people who use alcohol in Rhode Island Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-04-16 Alexandra B. Collins, Michael Tan, Megan Smith, Sara J. Becker
IntroductionAlcohol is a leading cause of morbidity and mortality in the United States and people who are unstably housed are disproportionately impacted by adverse alcohol‐related health outcomes. Addressing the needs of unstably housed people with high‐intensity alcohol use (i.e., heavy episodic use or binge drinking), including those whose goal is not abstinence, is critical to reducing harms among
-
Effectiveness of web‐based personalised feedback interventions for reducing alcohol consumption among university students: A systematic review and meta‐analysis Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-04-10 María Pueyo‐Garrigues, Hannah Carver, Amy Parr, María Lavilla‐Gracia, Cristina Alfaro‐Díaz, Nuria Esandi‐Larramendi, Navidad Canga‐Armayor
IssuesMeta‐analysis was conducted to examine standalone web‐based personalised feedback interventions (PFI) delivered in non‐structured settings for reducing university students' alcohol consumption. Subgroup analyses by gender‐focus, type‐of‐content and accessibility were conducted. Characteristics of the sample, the intervention and study quality were examined as moderators.ApproachTen databases
-
The ‘missing’ in the ‘endgame’ of hepatitis C elimination: A qualitative study in New South Wales, Australia Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-04-10 Carla Treloar, Kari Lancaster, Tim Rhodes, Lise Lafferty, Joanne Bryant, Jake Rance
IntroductionAfter a promising start in Australia, elimination efforts for hepatitis C are not on track. Following the global campaign to ‘find the missing’ in hepatitis C response, this qualitative study explores stakeholder perspectives on the ‘missing’ in the ‘endgame’ of hepatitis elimination in the state of New South Wales, Australia.MethodTwenty‐eight key informants working in New South Wales
-
Where do high‐risk drinking occasions occur more often? A cross‐sectional, cross‐country study Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-04-08 Alexandra Torney, Robin Room, Heng Jiang, Taisia Huckle, John Holmes, Sarah Callinan
IntroductionThe current paper examines the proportion of drinking occasions and total alcohol consumed that takes place at off‐premise locations. Comparisons are made between high‐income countries: Australia, New Zealand, England and Scotland, and across drinker‐types: high‐risk and lower‐risk.MethodsData were taken from the International Alcohol Control study in Australia (N = 1789), New Zealand (N
-
Cannabidiol use in France in 2022: Results from a nationwide representative sample of adults Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-04-02 Tangui Barré, Emmanuel Lahaie, Vincent Di Beo, Patrizia Carrieri, Raphaël Andler, Viêt Nguyen‐Thanh, François Beck
IntroductionCannabidiol (CBD) is a non‐intoxicating cannabis compound found in diverse commercial products worldwide. However, its use may not be fully harmless. Accordingly, it is important to document the prevalence of CBD use and user characteristics in the general population.MethodsWe conducted a nationwide survey from a random sample of adults living in France using computer‐assisted telephone
-
The burden of prenatal and early life maternal substance use among children at risk of maltreatment: A systematic review Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-28 Madeleine Powell, Rhiannon Pilkington, Bianca Varney, Alys Havard, John Lynch, Timothy Dobbins, Julee Oei, Tasnia Ahmed, Kathleen Falster
Although maternal substance use is a known risk factor for child maltreatment, evidence on the scale of substance use is needed to inform prevention responses. This systematic review synthesised prevalence estimates of maternal substance use during pregnancy and early life among children at risk of maltreatment. Ovid, Pubmed, CINAHL, PsychInfo and ProQuest databases were searched. We included observational
-
Diverting attention away from novel approaches to preventing opioid overdose deaths Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-27 Carol Strike, Adrian Guta, Rose Schmidt
-
More data on opioid diversion is needed Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-27 Leonora Regenstreif, Mel Kahan
-
Time to reconsider the best practice models of substance use care for young people Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-21 Maja L. Moensted, Sophia Little, Paul Haber, Carolyn Day
1 INTRODUCTION The NSW Government announced on 21 September 2022 a half-a-billion dollar investment to deliver targeted health and justice reforms in response to the Special Commission of Inquiry into the Drug Ice. A total of $358 million over 4 years will be directed towards health-related programs including evidence-based treatment, support and early intervention services for priority populations
-
Trends in purchasing cross‐border, illicit and home‐brewed alcohol: A population study in Great Britain, 2020–2023 Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-21 Sarah E. Jackson, Melissa Oldham, Colin Angus, John Holmes, Jamie Brown
IntroductionThe last 3 years have seen substantial changes in Great Britain (GB) including the COVID‐19 pandemic, cost‐of‐living crisis and policy changes such as minimum unit pricing. We examined changes in purchasing cross‐border, illicit and home‐brewed alcohol among risky drinkers over this period.MethodsData were used from 22,086 adult (≥18 years) increasing/higher‐risk drinkers (AUDIT‐C ≥5) participating
-
Self‐change from problems with alcohol and drugs: A scoping review of the literature since 2010 Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-19 Florian De Meyer, Nellie Bencherif, Clara De Ruysscher, Lou Lippens, Wouter Vanderplasschen
IssuesSelf‐change from alcohol and drug use problems is increasingly acknowledged in research. Despite the growing number of published studies, the most recent broad review of this dispersed field dates back to 2010. The present review narratively synthesises key findings from empirical studies and critically identifies research gaps and directions for further research.ApproachFollowing the PRISMA
-
The absence of mandatory pregnancy warning labels in online alcohol purchasing contexts Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-19 Simone Pettigrew, Tazman Davies, Paula O'Brien, Bella Sträuli, Mark Petticrew, Jacquie Bowden
IntroductionAs people increasingly migrate to online shopping platforms, hard‐won improvements in requirements for consumer information provision at the point of sale are being eroded. An example is the alcohol pregnancy warning label for packaged alcoholic beverages that has been recently introduced in Australia and New Zealand. The aim of the present study was to assess the extent to which the pregnancy
-
Prevalence and factors associated with polydrug use among clients seeking treatment for alcohol misuse Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-11 Samuel Lawson, Jamie Bryant, Megan Freund, Joshua Dizon, Paul S. Haber, Anthony Shakeshaft, Meryem Jefferies, Michael Farrell
IntroductionThe aim of this paper was to examine the client and psychosocial characteristics associated with polydrug use in patients with alcohol misuse as their primary drug of concern (PDC) seeking treatment from substance use treatment centres.MethodsSelf‐report surveys were undertaken with clients attending 1 of 34 community‐based substance use treatment centres across Australia with alcohol as
-
Young people's alcohol use in and around water: A scoping review of the literature Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-10 Renee N. Carey, Gemma Crawford, Jonine Jancey, Tina Lam, Lauren Nimmo, Gina Trapp, Christina Pollard, Paula Hooper, Justine E. Leavy
IssuesThe surrounding social and commercial context, including alcohol advertising, heavily influences alcohol consumption. Alcohol use is a major risk factor for both fatal and non‐fatal drowning, particularly for young people.ApproachWe conducted a scoping review to explore the peer‐reviewed literature on the use of alcohol by young people (aged 15–34 years) in the context of aquatic environments
-
Smartphone‐delivered approach bias modification for reducing harmful drinking amongst middle–older age adults: Secondary analyses of a single‐arm pilot study Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-06 Georgia L. Bolt, Hugh Piercy, Jennifer Bradshaw, Victoria Manning
IntroductionNovel, scalable, low‐cost interventions are needed to reduce harmful drinking amongst middle–older adults. Approach bias modification (ApBM) is a promising form of cognitive training for preventing/reducing alcohol use that can be delivered via smartphone. This study explored the acceptability and preliminary effectiveness of smartphone delivered and personalised ApBM amongst Australians
-
Psychological predictors of vaping uptake among non‐smokers: A longitudinal investigation of New Zealand adults Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-04 Tamlin S. Conner, Grace E. Teah, Chris G. Sibley, Robin M. Turner, Damian Scarf, Andre Mason
IntroductionDemographic and health factors are known to predict vaping. Less is known about psychological predictors of vaping uptake, particularly among non‐smoking adults using longitudinal designs. We aimed to model how psychological factors related to personality and mental health predicted the likelihood of vaping uptake over time in non‐smoking adults ages 18+ using longitudinal data.MethodsLongitudinal
-
Adulteration and substitution of drugs purchased in Australia from cryptomarkets: An analysis of Test4Pay Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-04 Monica J. Barratt, Matthew Ball, Gabriel T. W. Wong, Angus Quinton
IntroductionProhibited drugs in unregulated markets may be adulterated, resulting in increased risks for people who use drugs. This study investigated levels of drug adulteration and substitution of drugs purchased in Australia from cryptomarkets.MethodsData were collected from a darknet forum called Test4Pay from 1 September 2022 to 23 August 2023. Posts were included if they reported the results
-
A multicentre case series of analytically confirmed gamma-hydroxybutyrate intoxications in Western Australian emergency departments: Pre-hospital circumstances, co-detections and clinical outcomes Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-01 Jennifer L. Smith, Shaun Greene, David McCutcheon, Courtney Weber, Ellie Kotkis, Jessamine Soderstrom, Bianca Douglas, Simon Lenton, Jodie Grigg, Paul Dessauer, Nadine Ezard, Daniel M. Fatovich
Gamma-hydroxybutyrate (GHB) use is associated with high risk of accidental overdose. This study examined the pre-hospital circumstances, demographic characteristics and clinical outcomes of analytically confirmed GHB emergency department (ED) presentations in Western Australia (WA).
-
-
-
Buprenorphine microdosing regimen using transdermal buprenorphine patches to transition from methadone to buprenorphine Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-26 Thileepan Naren, Jon Cook, Paul MacCartney, Dean Membrey
This case series records a cohort of patients treated with transdermal buprenorphine patches as part of a buprenorphine microdose induction protocol to transition from methadone to buprenorphine in a community setting. This has historically been a difficult process to manage in community settings and this case series explored a method to gradually manage this in an outpatient setting.
-
Increases in the use of drug testing kits among nightclub and festival attendees in New York City who use ecstasy, 2017–2022 Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-26 Nicole D. Fitzgerald, Joseph J. Palamar
Ecstasy (3,4-methylenedioxymethamphetamine [MDMA]) is a drug commonly used by people who attend electronic dance music (EDM) events at nightclubs and dance festivals. Drug checking has gained popularity in recent years to test for adulterants, but epidemiology studies are needed to estimate potential shifts in prevalence of drug checking to further inform harm reduction efforts.
-
Youth drinking in decline: Recent developments and future priorities Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-26 Michael Livingston, Nic Taylor, Jonas Raninen, Amy Pennay
The decline in young people's drinking across high income countries has been a topic of research for nearly a decade now, with studies clearly establishing declines in drinking across a range of measures and settings [1, 2]. Meanwhile efforts to pin down clear drivers of these trends or to better understand their longer-term implications have produced less consistent results [3]. As has been argued
-
Health utility among people who regularly use opioids in Australia Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-26 Anh Dam Tran, Jason Grebely, Mark Chambers, Louisa Degenhardt, Michael Farrell, Sahar Bajis, Briony Larance
IntroductionStudies of health utilities among people who use opioids have mostly been based on in‐treatment populations. We aim to report utility‐based quality of life by participants' socio‐demographic, drug and treatment characteristics, and to examine the determinants of health utility among people who use opioids regularly.MethodsCross‐sectional study of participants who used opioids regularly
-
Socio-economic inequities in emergency department visits for wholly alcohol-attributable acute and chronic harms in Canada, 2003–2017 Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-22 Claire Benny, Erin Hobin, Alessandra T. Andreacchi, Naomi Schwartz, Brendan T. Smith
Individuals with low socio-economic position (SEP) experience disproportionate alcohol-attributable harm. Limited research has investigated whether these inequities are driven by alcohol-attributable conditions that are acute or chronic. The study aimed to estimate the sex-specific associations between SEP and incident wholly alcohol-attributable emergency department (ED) visits for acute and chronic
-
Characteristics, toxicology and major organ pathology of deaths due to acute alcohol toxicity in Australia, 2011–2022 Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-12 Shane Darke, Johan Duflou, Amy Peacock, Agata Chrzanowska, Wing See Yuen, Michael Farrell, Julia Lappin
Acute alcohol toxicity is a significant component of alcohol-related mortality. The study aimed to: (i) determine the circumstances of death and characteristics of fatal alcohol toxicity cases, 2011–2022; (ii) determine their toxicological profile and major autopsy findings; and (iii) determine trends in population mortality rates.
-
Differences in stigma reduction related to injection drug use between people expressing conservative, moderate and progressive values following an online intervention Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-12 Theresa Caruana, Loren Brener, Sarah K. Calabrese, Elena Cama, Carla Treloar, Timothy Broady
Contact interventions have shown short-term effectiveness in reducing stigmatising attitudes and behaviours of the public towards marginalised population groups, including people who inject drugs. We theorised that the effectiveness of an intervention differs according to peoples' underlying social values and undertook a study to test this.
-
Policies for recovery from drug use: Differences between public stigma and perceived stigma and associated factors Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-07 Tingyu Luo, Shuping Xu, Kun Zhang
Public stigma towards people who use drugs is widespread and places obstacles in way of their recovery. Previous studies have used different approaches to measure public stigma, resulting in a notable gap in the understanding of the relationship between it and its associated factors. Some studies measure public stigma by assessing stigma perceived by those who use drugs, while others investigate attitudes
-
Approaches and reporting of alcohol and other drug testing for injured patients in hospital-based studies: A systematic review Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-05 Georgina Lau, Jia Y. Ang, Nayoung Kim, Belinda J. Gabbe, Biswadev Mitra, Paul M. Dietze, Sandra Reeder, Ben Beck
Hospital alcohol and/or other drug (AOD) testing is important for identifying AOD-related injuries; however, testing methods vary. This systematic review aimed to examine biological AOD testing methods from hospital-based studies of injured patients and quantify what proportion reported key information on those testing methods.
-
Alcoholic beverage types consumed by population subgroups in the United States: Implications for alcohol policy to address health disparities Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-05 Won Kim Cook, William C. Kerr, Yachen Zhu, Sophie Bright, Charlotte Buckley, Carolin Kilian, Aurelie M. Lasserre, Laura Llamosas-Falcón, Nina Mulia, Jürgen Rehm, Charlotte Probst
We aimed to identify alcoholic beverage types more likely to be consumed by demographic subgroups with greater alcohol-related health risk than others, mainly individuals with low socio-economic status, racial/ethnic minority status and high drinking levels.
-
Effects of the Sacramento Neighborhood Alcohol Prevention Project on rates of child abuse and neglect 7 years post-implementation (1999–2010) Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-30 Bridget Freisthler, Jennifer Price Wolf
Evaluations of alcohol environmental prevention efforts examine short-term effects of these interventions on alcohol-related problems. We examine whether the effects of the Sacramento Neighborhood Alcohol Prevention Project (SNAPP), an alcohol environmental intervention aimed to reduce alcohol-related problems in two neighbourhoods, on child abuse and neglect remained 7 years post-implementation.
-
Typologies of alcohol and other drug-related risk among lesbian, gay, bisexual, transgender (trans) and queer adults Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-30 Thomas Norman, Adam Bourne, Natalie Amos, Jennifer Power, Joel Anderson, Gene Lim, Marina Carman, G. J. Meléndez-Torres
Prevalence and patterns of alcohol and other drug (AOD) use among specific lesbian, gay, bisexual, transgender (trans) and queer (LGBTQ+) subpopulations are well established. However, patterns of substance-related risk have been less thoroughly explored. This study aimed to determine typologies AOD risk among LGBTQ+ adults in Australia.
-
Acute REM sleep behaviour disorder associated with alcohol withdrawal: A case report and literature review Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-29 Radhika Chakraborty, Tathagata Biswas, Biswa Ranjan Mishra, Arpit Parmar
Rapid eye movement (REM) sleep behaviour disorder (RBD) is a parasomnia characterised by the loss of REM sleep muscle atonia and the enactment of dreams. Acute RBD associated with alcohol withdrawal syndrome is known, but the studies are limited, particularly on its neurobiological underpinnings and management alongside the withdrawal state. This work attempts to address this using a case study and
-
Advancing the implementation of take-home naloxone by community pharmacists: Testing the role of COM-B Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-29 Joanna C. Moullin, Lexy Staniland, Hannah Uren, Suzanne Nielsen, Simon Lenton
Opioid-related overdose fatalities are rising despite the increased accessibility of take-home naloxone (THN). Targeted implementation strategies are needed to improve the distribution of naloxone. This study investigates the effectiveness of a short video targeting pharmacists that addresses implementation barriers.
-
How did COVID-19 restrictions impact alcohol consumption in Australia? A longitudinal study Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-28 Yvette Mojica-Perez, Michael Livingston, Amy Pennay, Sarah Callinan
The state of Victoria experienced more stringent public health measures than other Australian states during the COVID-19 pandemic. This study investigated how these public health measures impacted: (i) total alcohol consumption; (ii) location-specific consumption; and (iii) consumption among different pre-pandemic drinking groups, in Victoria compared to the rest of Australia during the first year
-
Experiences of stigma and subsequent reduced access to health care among women who inject drugs Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-25 Loren Brener, Elena Cama, Timothy Broady, Mary Ellen Harrod, Carol Holly, Theresa Caruana, Kim Beadman, Carla Treloar
Research into stigma and injecting drug use has typically involved predominantly male participants, with limited research about the unique experience of women who inject drugs.
-
Harm perceptions of vaping nicotine relative to cigarette smoking among sexual and gender minority young adults Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-23 Sharon Lipperman-Kreda, Emile Sanders, Rachelle Annechino, Elaina Peterkin, Tamar M. J. Antin
To address gaps in existing research, the current study used a mixed-methods approach to describe, contextualise and understand harm perceptions of vaping nicotine relative to cigarette smoking and associations with nicotine and tobacco (NT) use among young adults who identify their genders and sexualities in ways that classify them as sexual and gender minorities (SGM).
-
Did the association between alcohol outlet density and crime change during COVID shelter-in-place orders? Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-23 Sharon E. O'Hara, Mallie J. Paschall, Joel W. Grube, William R. Ponicki
We investigated whether greater concentrations of on- and off-sale alcohol outlets were associated with crime and whether this association was moderated by COVID-19 shelter-in-place orders (SIP) that restricted on-premises consumption of alcohol.
-
Impacts of Northern Territory banned drinker register on police recorded youth assault Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-17 Ryan Baldwin, Peter G. Miller, Kerri Coomber, Debbie Scott, Yin Paradies
In September 2017 the Northern Territory Government of Australia introduced a banned drinker register (BDR) to mitigate the high levels of alcohol-related harm within the Northern Territory. The current study aimed to examine the impact of the Northern Territory BDR on youth (aged <18 years) using police recorded assault data.
-
Individuals' travel to alcohol outlets: The fallacy of the local bar Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-11 Christina A. Mehranbod, Ariana N. Gobaud, Brady R. Bushover, Christopher N. Morrison
Studies relating alcohol outlet density around homes to alcohol consumption produce mixed results. One possible explanation is that people travel to outlets away from their homes. This study aims to characterise individuals' trips to outlets, describe these trip locations relative to other activities and estimate associations between alcohol outlet density and trips to outlets.
-
Factor structure of the alcohol expectancies questionnaire among adolescents in rural Ghana Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-06 Benedict Weobong, Rebecca L. Monk, Maria Anyorikeya, Adam W. Qureshi, Derek Heim
Children's early experiences with alcohol inform the development of alcohol-related beliefs which are known to predict alcohol consumption during the critical stage of adolescence. Yet, there has been considerably less research into these alcohol-related cognitions in low- and middle-income countries (LMIC) and existing measures of these beliefs are highly reflective of Western contexts, which may
-
The economic costs of alcohol-related harms at the local level in New South Wales Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-03 Paul Crosland, Mary Rose Angeles, Jonathon Noyes, Arlita Willman, Melissa Palermo, Paul Klarenaar, Eloise Howse, Jaithri Ananthapavan
Alcohol is a harmful, toxic and addictive substance that causes many diseases and injuries. Alcohol use also incurs a financial cost to the health care system and wider economy. This project aimed to undertake a cost impact analysis of alcohol-related harms at the local level in New South Wales (NSW). The alcohol-related harms costing model is an interactive tool designed for use by local health districts
-
Experiences of telehealth among people receiving alcohol and other drug treatment during the COVID-19 pandemic: Implications for future telehealth delivery Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-28 Jaimie Woolley, Michael Savic, Joshua B. B. Garfield, Rachel Petukhova, Victoria Manning, Dan I. Lubman, Anthony Barnett
The novel coronavirus (COVID-19) pandemic necessitated the rapid uptake of telehealth to deliver treatment for alcohol and other drug (AOD) concerns. However, little is known about how the move from in-person to telehealth delivery impacted clients' experience of care. This qualitative study aimed to explore experiences of telehealth among people receiving alcohol and other drug treatment during the
-
Parents who inject drugs: Demographics, care arrangements and correlates for child placement in out-of-home care Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-26 Jocelyn Chan, Bernadette Ward, Lisa Maher, Sione Crawford, Mark Stoové, Paul Dietze
Children in families affected by substance use disorders are at high risk of being placed in out-of-home care (OOHC). We aimed to describe the characteristics of parents who inject drugs and identify correlates associated with child placement in OOHC.
-
A snapshot of injecting drug consumption from the analysis of used syringes within the Medically Supervised Injecting Centre in Sydney, Australia Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-25 Harrison Fursman, Eleanor Finch, Linda Xiao, Elodie Lefrançois, Anjali Gupta, Mark Bartlett, Julie Latimer, Scott Chadwick, Claude Roux, Marie Morelato
The administration of illicit drugs by injection is associated with considerable harm, including an increased risk of overdose. The chemical analysis of used syringes can enhance knowledge on injecting drug consumption beyond traditional data sources (self-report surveys). This additional information may be useful during significant global events like the COVID-19 pandemic. This study aimed to examine
-
Hepatitis C virus cure from direct-acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort) Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-22 Tangui Barré, Marc Bourlière, Lucia Parlati, Clémence Ramier, Fabienne Marcellin, Camelia Protopopescu, Vincent Di Beo, Carole Cagnot, Celine Dorival, Jérôme Nicol, Fabien Zoulim, Fabrice Carrat, Patrizia Carrieri
The risk of mortality in people with a history of injection drug use (PHID) is high, as is the prevalence of hepatitis C virus (HCV) infection. Although direct-acting antivirals (DAA) are effective in this population in terms of sustained virological response, it is not known whether PHID benefit as much as people with no history of injection drug use from DAA-related HCV cure in terms of reduced all-cause
-
Tobacco consumption in Mozambique in 2005 and 2015 Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-22 Filipa Fontes, António Suleman, Carla Silva-Matos, Celina Mate, Celeste Amado, Albertino Damasceno, Nuno Lunet
The burden related to smoking exposure is growing in many low-income settings. We aimed to quantify the use of smoked and smokeless tobacco in Mozambique in 2014/2015, and to compare the estimates with those obtained in 2005.
-
Cannabis vaporisation: Understanding products, devices and risks Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-20 Caroline A. MacCallum, Lindsay A. Lo, Carly A. Pistawka, April Christiansen, Michael Boivin
Vaporisation is a common method of cannabis administration. Inconsistent terminology and jargon regarding vaporisation has led to confusion. The increasing public interest and access to cannabis, combined with possible safety concerns associated with certain cannabis vaping products, warrants improved consumer and public and health care professional knowledge.
-
Future nicotine use preferences of current cigarette smokers: Findings from the 2020 International Tobacco Control Four Country Smoking and Vaping Survey Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-19 Lin Li, Ron Borland, Michael Le Grande, Coral Gartner
Consumer preferences should be important factors that are considered when developing health policies and interventions. This paper examines the prevalence of, and factors associated with, consumer preferences regarding smoking behaviour 1 to 2 years in the future.
-
Have the personality and socio-demographic profiles of Australian adolescent drinkers changed? Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-18 Nicholas Taylor, Sarah Callinan, Amy Pennay, Michael Livingston
Adolescent alcohol consumption has been declining across many countries, with rates of abstinence also increasing among younger cohorts. A range of socio-demographic variables and personality traits are associated with alcohol use; however, no study has examined whether the relationship between personality and drinking has changed over time as adolescent drinking has declined.
-
Barriers and facilitators to the implementation of the Flinders Chronic Condition Management Program in outpatient drug and alcohol settings in Australia Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-14 Candice Oster, Sarah Hunter, Timothy Schultz, Gillian Harvey, Michael Lawless, Malcolm Battersby
There has been a growing call for drug and/or alcohol dependence to be managed as a chronic condition. The Flinders Chronic Condition Management Program (Flinders Program) was implemented in a drug and alcohol service in Australia in 2019–2022 to explore the feasibility of chronic condition management in outpatient clinics. Implementation involved: adaptation of the Flinders Program; adaptation of
-
Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-14 Benedikt Fischer, Tessa Robinson, Didier Jutras-Aswad
Canada has been experiencing a prolonged public health-crisis of high rates of overdose deaths caused by exceptionally potent/toxic, illicit opioid use. While many key features of this drug death epidemic are well-documented, several idiosyncratic aspects with relevance for public health-oriented interventions are not adequately recognised. These include: (i) the discrepant opioid patterns pan-Canada